![3-[4-Hydroxy-3-[5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-3-(Pentyloxy)-2-Naphthalenyl]Phenyl]-2-Prop…](https://static.cymitquimica.com/cas-image/404687-3-4-hydroxy-3-5678-tetrahydro-5588-tetramethyl-3-pentyloxy-2-naphthalenyl-phenyl-2-propenoicacid.png)
CAS: 847239-17-2 - 3-[4-Hydroxy-3-[5,6,7,8-Tetrahydro-5,5,8,8-Tetramethyl-3-(Pentyloxy)-2-Naphthalenyl]Phenyl]-2-Propenoicacid
Formula:C28H36O4
- Synonyms:
- 3-[4-Hydroxy-3-(5,5,8,8-Tetramethyl-3-Pentoxy-6,7-Dihydronaphthalen-2-Yl)Phenyl]Prop-2-Enoic Acid
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | UVI 3003 REF: IN-DA008GQ3CAS: 847239-17-2 | 98% | To inquire | Wed 04 Dec 24 |
 | UVI 3003 REF: 54-BISN0065CAS: 847239-17-2 | 98% | 67.00 € | Thu 05 Dec 24 |
 | UVI 3003 REF: TM-T17209CAS: 847239-17-2 | 99.94% | 35.00 €~594.00 € | Wed 11 Dec 24 |
 | UVI 3003 REF: 3D-XIB23917CAS: 847239-17-2 | Min. 95% | To inquire | Wed 15 Jan 25 |
Ref: IN-DA008GQ3
| 1mg | 50.00 € | ||
| 5mg | 108.00 € | ||
| 10mg | 149.00 € | ||
| 25mg | 211.00 € | ||
| 50mg | 473.00 € | ||
| 100mg | 569.00 € | ||
| 250mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: 54-BISN0065
| 5mg | 67.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
UVI 3003
CAS:847239-17-2
UVI 3003 blocks retinoid X receptor (RXRα) in Xenopus/human Cos7 cells; IC50: 0.22/0.24 μM.
Formula:
C28H36O4
Purity:
99.94%
Color and Shape:
Solid
Molecular weight:
436.58
Ref: TM-T17209
| 1mg | 35.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 74.00 € | ||
| 10mg | 118.00 € | ||
| 25mg | 237.00 € | ||
| 50mg | 398.00 € | ||
| 100mg | 594.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
UVI 3003
CAS:847239-17-2
UVI 3003 is a drug that is being developed for the treatment of cancer. It …
Formula:
C28H36O4
Purity:
Min. 95%
Molecular weight:
436.58 g/mol
Ref: 3D-XIB23917
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
